-
After a surgery for breast cancer, the use of radiotherapy reduces the risk of local relapses, but it is not clear which is the best interval of time between surgery and the beginning of RT. In this retrospective trial, 18,000 women averagely ≥ 65 with stage-0-2 breast cancer, treated with surgery and radiotherapy but not with chemotherapy, have been examined to determine whether the interval of time between surgery and radiotherapy can, in some way, influence prognosis.
MedNews (Oncology) - Mon, 28 February 2011
http://mn.medsurfnews.com/
-
Just 150 minutes of moderate physical activity a week can reduce the risk of breast and coloncancers. This is according to the new Global Recommendations onPhysical Activity for Health released by WHO today on World Cancer Day.
Health-EU (Oncology) - Mon, 7 February 2011
http://ec.europa.eu/health-eu/index_en.htm
-
Childhood cancer survivors, though being 'cured' of cancer, often experience late physical and psychological effects secondary to their cancer or its treatment. To accelerate the search for new successful treatments and improve the quality of life after cancer, 16 research institutes from 11 European countries have decided to join forces and launch a groundbreaking study funded by the EU.
Health-EU (Oncology) - Mon, 7 February 2011
http://ec.europa.eu/health-eu/index_en.htm
-
The new guidance focuses on how the NHS and local authorities can help prevent skin cancer using public information, sun protection resources and by making changes to the natural and built environment.
National Institute for Health and Clinical Excellence (Oncology) - Tue, 1 February 2011
http://www.nice.org.uk
-
Pancreatic cancer develops and spreads much more slowly than scientists have thought, according to new research from Johns Hopkins investigators. The finding indicates that there is a potentially broad window for diagnosis and prevention of the disease.
Johns Hopkins Hospital (Oncology) - Tue, 1 February 2011
http://www.hopkinshospital.org
-
Pancreatic cancer develops and spreads much more slowly than scientists have thought, according to new research from Johns Hopkins investigators. The finding indicates that there is a potentially broad window for diagnosis and prevention of the disease. After the first cancer cell appears, it takes an average of nearly seven years for that cell to turn into the billions that make up a cancerous tumor the size of a plum, after which at least one of the cells within the tumor has the potential and ability to spread to other organs. Patients die an average of two and a half years after this metastasis.
Johns Hopkins Hospital (Oncology) - Tue, 1 February 2011
http://www.hopkinshospital.org
-
Beside the important role of vitamin D in calcium homeostasis, from some small prospective trials, it seems that this substance also intervenes in the prevention of colorectal cancer: in fact, an inverse association between plasmatic levels of 25(OH)-D and the presence of colorectal cancer has been noted.
MedNews (Oncology) - Tue, 1 February 2011
http://mn.medsurfnews.com/
-
Anti-androgen therapy, administered in the treatment of prostate cancer, implies the use of agonists of gonadotropin-releasing hormone (GnRH), like leuprolide and goserelin, beside oral anti-androgens, like flutamide and bicalutamide.
MedNews (Oncology) - Wed, 12 January 2011
http://mn.medsurfnews.com/
-
Daily aspirin reduced deaths due to several common cancers during and after the trials. Benefit increased with duration of treatment and was consistent across the different study populations. These findings have implications for guidelines on use of aspirin and for understanding of carcinogenesis and its susceptibility to drug intervention.
The Lancet (Oncology) - Mon, 3 January 2011
http://www.thelancet.com
-
In a case-control trial, performed in Canada, the performance of colonoscopy has been associated with a decrease in the mortality for left colon cancer, but it has not influenced the mortality for right colon cancer. In another trial, some researchers in Germany have considered the problem, making 3287 subjects ≥ 55 years of age undergo colonoscopy screening; out of these, 586 had undergone a previous colonoscopy averagely 5 years before, while 2701 had never performed screening.
MedNews (Oncology) - Wed, 29 December 2010
http://mn.medsurfnews.com/